Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138626	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.7;skin 1: 20.7"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.0;hippocampal formation: 1.1"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	5.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.2	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.8	0.3	3.9	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	38.7	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.5	0.1	2.7	0.0	18.3	0.0	0.2	9.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	12.9	0.9	6.0	0.0	0.2	1.0	0.5	0.5	0.0	5.1	0.0	0.0	1.1	0.0	3.0	0.0	0.1	2.2	2.6	0.3	0.1	0.0	0.0	1.4	0.0	2.7	0.1	1.5	3.7	0.0	0.5	0.0	0.0	0.4	1.7	2.9	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.6	1.9	0.0	0.7	0.0	1.0	0.0	0.1	3.1	0.2	0.0	0.0	0.2	0.7	0.4	2.2	38.6	3.4	0.0	0.1	0.9	2.7
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333612	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 88.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.7;Inhibitory neurons: 2.1;Melanocytes: 1.8;Spermatocytes: 1.7;Suprabasal keratinocytes: 5.8"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Cell line enhanced"	"Detected in single"		"T-47d: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	3.3	0.4	0.2	3.4	0.3	0.0	0.0	0.2	0.2	12.2	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.0	3.2	0.1	0.5	88.1	0.2	0.1	0.0	0.3	0.0	1.1	0.2	1.3	0.0	0.0	0.7	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.5	0.0	0.1	0.7	0.7	0.1	0.3	0.0	0.1	0.8	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.1	0.9	1.0	1.8	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.7	1.0	0.0	5.8	0.0	0.4	0.0	0.0	0.1
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 6.6;lymphoid tissue: 2.6;skin 1: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 33.3;U-87 MG: 45.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.0	0.0	1.7	0.0	3.3	0.0	0.2	6.6	2.7	0.7	0.8	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.0	2.0	2.2	0.0	0.0	0.0	0.0	3.9	3.7	0.0	0.0	0.3	0.0	0.0	3.8	0.3	0.0	0.0	0.5	0.0	0.0	6.0	0.0	0.0	2.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	2.6	0.1	0.6	4.1	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.8	0.4	5.2	0.0	0.0	0.0	33.3	0.3	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.5	0.3	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.1	1.1	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	6.6	2.7	2.0	2.2	3.9	3.7	3.8	2.0	3.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978374	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 305.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 114.3;Basal respiratory cells: 83.8;Horizontal cells: 60.6;Ionocytes: 61.1;Pancreatic endocrine cells: 68.2;Respiratory ciliated cells: 66.8;Squamous epithelial cells: 63.7;Suprabasal keratinocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 135.1;HBEC3-KT: 124.9;hTCEpi: 308.7;hTERT-HME1: 130.3;TIME: 138.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"medulla oblongata: 11.3;midbrain: 10.6;pons: 13.2;spinal cord: 38.9;thalamus: 15.0"	"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		40000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.23e-5)"	30.4	2.3	9.8	2.4	9.9	0.0	16.4	9.3	15.9	84.5	4.6	105.3	1.4	64.3	2.9	114.1	29.2	5.1	4.5	9.7	16.0	3.5	6.2	5.1	0.1	38.1	15.3	3.5	1.6	0.7	3.4	1.8	40.8	18.6	8.6	19.0	24.0	28.6	3.6	305.9	20.2	31.6	12.4	0.9	25.2	7.7	18.1	0.4	2.8	4.5	4.7	49.4	86.6	18.5	2.9	107.6	0.1	6.0	120.0	135.1	0.2	10.5	22.3	3.8	1.9	0.3	38.9	0.1	14.5	82.9	85.3	62.9	0.3	124.9	1.7	0.0	0.4	0.0	67.5	0.5	11.0	0.0	3.8	17.6	308.7	12.1	130.3	52.3	54.7	0.0	0.0	0.2	62.8	8.0	0.0	0.0	0.3	9.5	42.9	0.3	5.7	0.1	84.4	0.0	0.6	0.6	46.2	0.1	2.3	2.8	6.0	0.0	138.4	29.3	17.9	33.8	9.9	0.0	0.0	0.0	88.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.8	9.9	9.3	15.9	9.7	16.0	38.1	15.3	40.8	12.4	18.1	18.5	3.8	12.8	1.1	0.3	0.0	114.3	4.9	83.8	13.1	8.9	2.2	1.3	1.5	0.0	38.2	1.8	2.1	0.2	0.3	0.4	0.0	11.9	24.2	16.0	10.5	13.0	0.0	0.0	8.2	8.7	0.5	31.9	0.0	18.9	17.1	0.1	3.6	2.1	1.0	60.6	5.1	0.0	61.1	0.3	12.7	3.1	0.6	0.7	32.0	3.7	0.0	3.2	0.0	1.5	3.3	68.2	0.0	0.4	0.0	4.5	0.0	0.3	66.8	13.9	0.0	13.1	8.6	0.4	4.3	63.7	164.7	0.1	0.9	0.1	0.2	6.2
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087716	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 90.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Vesicles,Cytosol		NA	NA		7000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Vesicles	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.0	0.0	0.4	0.1	0.5	0.1	2.1	0.4	0.6	5.7	0.0	0.1	0.3	0.0	0.0	5.6	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.4	0.2	0.0	0.2	1.2	0.1	0.0	0.5	0.4	0.1	0.6	0.8	0.0	0.4	90.2	0.2	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.0	0.0	19.1	0.0	15.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.2	0.0	0.0	1.6	0.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.0	0.9	0.0	0.4	0.4	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.4	0.6	0.1	0.2	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.5	0.4	0.6	0.4	0.2	0.4	0.2	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	1.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982249-150995634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 61.5;Collecting duct cells: 12.9;Ductal cells: 21.2;Hepatocytes: 17.4;Proximal tubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;granulocytes: 1.0;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.6;Hep G2: 42.3;MCF7: 59.2;OE19: 47.8;T-47d: 139.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	3.2	3.7	2.6	2.6	7.1	2.4	6.9	6.1	3.5	2.2	3.3	2.1	4.6	6.4	5.9	26.2	4.7	9.2	6.0	1.7	3.5	22.0	29.9	3.1	2.3	9.0	6.7	4.7	35.8	19.2	1.2	1.0	7.9	2.4	0.3	7.2	7.5	21.2	3.8	32.4	4.2	2.9	4.5	2.8	4.2	3.8	5.3	0.5	25.0	0.2	23.2	6.3	6.0	12.1	11.7	2.8	4.2	4.4	0.0	0.0	11.4	1.0	0.8	0.1	0.0	33.9	40.6	0.4	2.5	0.0	1.3	6.8	0.0	0.8	0.1	3.9	4.4	6.1	4.7	42.3	0.0	2.4	2.6	0.0	0.3	0.1	0.2	9.5	0.0	1.8	3.0	13.2	0.1	59.2	0.5	3.2	1.1	47.8	0.8	2.8	0.6	15.0	0.1	17.0	6.4	3.6	2.6	28.8	1.7	2.3	139.9	3.7	4.7	0.9	1.3	0.7	0.8	4.0	13.0	18.8	6.2	4.2	3.3	0.0	1.2	0.7	0.0	0.7	0.3	0.2	0.1	0.2	1.6	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.4	2.6	7.1	6.1	3.5	1.7	3.5	9.0	6.7	7.9	4.5	5.3	12.1	0.1	0.0	1.1	0.3	0.2	0.1	0.4	0.8	0.0	0.0	4.5	2.5	0.4	61.5	4.5	12.9	0.0	2.0	0.1	0.0	3.9	21.2	1.5	1.3	0.8	0.1	0.0	0.0	0.2	7.5	0.3	0.6	0.0	1.6	1.3	0.0	0.0	17.4	2.2	0.0	0.2	0.0	0.0	0.6	0.4	0.9	1.5	1.4	1.8	0.0	0.2	0.0	0.0	1.0	0.5	2.9	0.1	1.2	0.0	0.3	0.3	44.6	2.5	0.0	0.0	0.1	0.3	4.9	0.2	0.3	0.0	1.5	0.2	0.0	0.3	5.4
ARFGAP2	"FLJ14576, IRZ, Zfp289, ZNF289"	ENSG00000149182	"ADP ribosylation factor GTPase activating protein 2"	Q8N6H7	11	47164299-47177125	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016649, HPA018152"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA016649: AB_1844980, HPA018152: AB_1844979"	"unprognostic (1.69e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.00e-2)"	"prognostic favorable (7.65e-7)"	"unprognostic (2.05e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.20e-2)"	38.0	51.4	62.1	36.3	63.9	82.2	41.7	63.2	68.3	42.3	57.2	49.4	40.0	43.3	35.5	60.8	49.3	32.1	58.7	62.5	60.1	47.6	76.8	40.7	51.9	65.1	61.8	44.6	69.7	48.2	38.7	39.9	61.8	51.4	39.4	38.9	56.1	41.7	115.9	78.7	43.8	38.8	60.6	51.2	55.7	30.7	63.1	49.8	47.4	81.4	50.5	44.7	43.3	70.3	55.7	36.4	54.9	43.3	45.9	37.3	51.6	51.2	48.1	64.1	48.4	41.3	45.3	91.3	32.4	58.7	40.8	82.3	47.2	74.6	40.3	45.0	46.1	77.6	85.5	50.8	53.7	107.0	84.4	56.7	82.3	33.3	71.1	46.1	60.4	65.6	111.8	67.8	58.5	102.5	50.8	87.8	43.6	98.3	48.4	78.8	94.8	116.8	60.3	79.3	53.0	47.0	58.7	81.7	38.8	26.1	126.8	78.8	48.7	55.2	43.3	50.5	68.6	58.6	60.7	78.3	38.6	81.2	56.4	108.5	69.1	92.8	74.0	77.3	66.6	59.0	57.1	66.2	65.9	63.1	63.0	63.4	41.8	69.2	98.4	35.4	71.8	108.1	62.1	63.9	63.2	68.3	62.5	60.1	65.1	61.8	61.8	60.6	63.1	70.3	23.8	35.3	45.9	25.1	46.5	22.2	31.4	22.1	29.6	73.6	30.9	25.8	13.0	20.0	41.2	31.3	114.7	64.3	40.7	38.6	25.4	38.7	2.7	20.3	26.4	29.8	45.4	47.1	16.2	36.6	47.1	29.7	34.1	27.0	60.8	44.9	31.1	44.0	36.8	74.0	15.1	35.0	38.7	33.6	25.4	6.6	34.2	28.6	28.4	15.9	58.1	51.1	71.1	13.0	23.7	39.2	45.0	26.4	31.7	26.4	41.0	26.3	34.1	115.4	39.5	33.0	28.0	24.7	35.9	30.3	26.7	91.8	43.7	40.3	36.3	34.0
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 573.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 777.0;Hofbauer cells: 921.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 392.8;SK-MEL-30: 590.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	214.3	71.9	50.1	51.6	51.5	107.7	95.8	62.1	50.8	98.5	62.6	84.3	54.7	55.8	131.5	73.2	70.4	99.1	573.9	49.9	66.2	204.0	60.9	190.3	65.9	66.0	59.4	50.1	49.6	117.8	83.6	121.5	69.0	84.3	87.0	79.5	66.6	77.9	66.0	52.6	56.8	61.7	66.3	85.4	61.2	18.2	59.1	26.0	325.5	70.7	57.7	112.8	54.8	102.2	48.1	66.4	25.9	63.3	392.8	46.0	39.2	48.2	67.3	23.0	41.0	35.4	66.1	30.2	60.3	54.5	159.1	62.6	15.0	25.3	28.4	22.9	38.9	134.4	46.7	96.7	107.5	27.7	140.7	100.2	86.5	33.6	22.9	53.2	6.2	50.6	24.3	61.7	67.9	46.0	15.5	48.3	30.3	105.2	40.5	19.4	25.5	41.4	112.0	273.0	40.4	55.0	43.8	145.2	590.5	35.6	47.9	31.3	43.6	30.3	43.1	55.8	23.7	75.5	184.3	22.0	89.5	61.3	24.6	285.2	455.4	318.7	47.6	676.4	43.1	83.9	35.5	36.1	175.1	65.9	40.8	37.9	627.6	60.5	731.4	33.0	43.7	407.2	50.1	51.5	62.1	50.8	49.9	66.2	66.0	59.4	69.0	66.3	59.1	102.2	98.5	317.3	405.0	36.9	92.8	58.6	83.3	103.7	35.3	97.5	105.6	87.8	777.0	100.1	280.9	450.6	45.9	177.4	67.6	83.4	60.7	150.6	2.8	85.7	51.5	79.7	98.1	106.3	49.8	104.1	65.2	122.0	43.3	133.8	257.0	49.3	134.6	50.6	921.2	77.4	53.2	99.3	201.4	564.3	89.9	6.0	88.6	524.6	318.4	56.2	259.2	532.6	53.5	49.8	49.0	64.7	125.5	105.7	87.4	87.8	77.6	304.2	147.3	88.0	177.5	74.5	157.0	14.0	63.6	84.9	64.2	148.2	61.3	53.4	89.7	139.9
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917211	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 16.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	16.4	20.1	11.4	6.5	10.9	60.2	16.9	8.6	40.1	19.9	11.4	18.9	7.5	18.2	1.8	15.7	19.2	4.2	18.4	11.5	9.8	22.0	59.2	24.2	6.1	13.9	12.3	24.9	22.7	4.9	21.6	4.9	12.7	21.6	2.6	1.9	15.2	5.7	26.7	34.9	21.4	3.3	9.0	25.7	23.2	15.3	11.4	5.4	19.3	4.4	3.3	17.7	15.6	10.4	13.2	12.6	4.4	12.0	5.7	4.0	12.3	7.1	10.3	9.4	6.8	11.0	9.9	9.3	14.7	6.0	12.0	10.8	4.5	8.3	2.5	9.1	15.7	8.7	19.1	10.0	8.4	6.5	18.2	10.9	7.1	11.8	6.3	5.4	7.9	9.5	16.1	7.3	4.1	21.3	7.8	21.9	5.1	3.5	14.3	8.6	7.1	13.5	5.0	10.9	16.5	6.7	10.6	14.6	13.3	3.3	14.3	8.1	10.1	9.0	8.6	18.3	5.3	14.7	5.5	6.5	13.0	5.2	5.6	3.0	2.0	2.2	2.5	2.1	2.1	0.8	1.7	2.2	1.4	0.9	1.3	2.4	16.9	1.8	1.7	2.4	0.9	1.2	11.4	10.9	8.6	40.1	11.5	9.8	13.9	12.3	12.7	9.0	11.4	10.4	9.8	9.6	16.2	20.2	17.0	28.9	8.7	35.7	16.5	16.6	15.8	10.3	8.1	7.2	17.6	9.2	33.3	12.7	40.1	38.8	1.9	10.2	2.5	12.4	9.2	10.2	35.9	16.2	7.6	10.3	5.3	12.6	16.8	24.4	9.5	15.4	7.9	23.2	10.9	13.5	8.4	17.6	24.4	20.1	19.9	3.6	12.8	24.2	30.2	5.6	11.9	12.3	19.6	6.6	7.1	14.9	21.7	10.1	27.3	12.2	26.8	6.6	13.3	26.0	13.1	11.6	10.6	9.0	6.2	16.3	38.4	66.9	40.2	27.2	19.0	15.9
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Metabolic proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;skin 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.7;Endometrial ciliated cells: 28.6;Late spermatids: 30.3;Respiratory ciliated cells: 25.9;Syncytiotrophoblasts: 115.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.9"	"Group enriched"	"Detected in some"	5	"BEWO: 13.0;CAPAN-2: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	1.1	0.4	1.7	0.2	0.2	0.4	1.0	1.7	0.3	0.0	0.0	0.4	1.1	8.3	1.0	0.2	0.0	0.5	2.1	0.0	0.0	0.2	0.8	2.0	1.7	0.1	0.0	0.0	1.5	4.1	1.1	0.2	0.0	0.8	0.5	0.0	0.2	11.5	0.0	0.0	1.0	0.1	0.1	2.0	2.1	0.3	0.1	0.0	0.8	0.1	1.6	0.4	0.6	0.0	0.7	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.1	4.2	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.5	0.4	0.6	0.0	1.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.0	1.0	0.9	5.0	1.3	0.0	1.6	8.9	3.4	0.0	0.4	0.1	0.7	5.4	1.4	1.1	1.7	0.4	1.0	0.5	2.1	2.0	1.7	1.1	1.0	2.1	0.4	0.4	0.0	0.0	0.0	2.8	0.0	0.2	1.9	0.6	4.0	0.7	0.9	1.4	1.5	1.6	0.0	0.0	10.2	1.5	0.3	0.0	0.3	50.7	28.6	3.3	1.1	0.0	0.0	2.7	0.2	2.5	0.5	0.0	15.4	14.7	7.8	2.2	0.0	1.9	0.0	7.7	0.0	4.1	0.3	0.4	30.3	0.6	0.8	0.0	0.0	0.3	0.5	1.0	0.5	0.6	3.8	0.0	0.7	0.4	0.3	0.0	0.1	25.9	0.6	0.0	0.0	0.9	19.8	12.7	0.8	0.3	115.5	4.7	0.1	0.2	1.9
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
C10orf95	FLJ14280	ENSG00000120055	"Chromosome 10 open reading frame 95"		10	102449837-102451543	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 30.1;Rod photoreceptor cells: 18.4;Syncytiotrophoblasts: 38.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.8;JURKAT: 11.7"	"Low region specificity"	"Detected in single"												"Secreted - unknown location"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (2.31e-1)"	"unprognostic (7.76e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.62e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.80e-3)"	0.5	1.5	0.7	1.8	0.6	2.0	0.2	2.8	1.1	1.1	0.9	1.2	2.5	1.2	0.4	1.3	9.7	1.4	0.6	0.6	0.8	1.4	0.4	3.5	2.9	0.3	0.2	1.1	4.7	0.1	1.3	0.7	0.1	1.6	0.4	4.7	4.0	0.1	0.7	4.1	2.3	0.0	0.0	2.6	3.6	0.7	0.9	0.0	5.3	0.0	0.5	0.6	0.5	0.1	5.7	1.1	0.1	2.3	0.0	0.0	4.9	0.2	0.0	0.0	0.0	4.4	9.8	5.0	2.2	0.0	0.7	9.8	0.0	0.4	0.0	4.3	11.8	3.2	4.7	3.7	0.0	4.4	3.0	0.1	1.8	0.0	0.1	3.1	0.0	11.7	5.6	4.1	0.0	4.5	2.4	4.2	2.2	2.0	3.3	7.0	0.1	5.4	1.1	2.0	8.8	1.3	2.4	1.5	3.1	1.7	4.8	0.3	0.4	0.2	1.0	0.2	0.5	3.5	2.9	3.3	0.2	6.5	0.1	2.1	1.2	1.7	7.8	0.6	7.4	10.7	8.4	7.9	3.6	8.3	11.7	9.9	0.9	10.1	0.3	6.3	9.6	4.9	0.7	0.6	2.8	1.1	0.6	0.8	0.3	0.2	0.1	0.0	0.9	0.1	0.3	0.0	3.2	0.7	3.1	1.5	4.3	0.5	0.0	4.6	2.4	2.5	0.1	2.8	4.2	5.5	10.4	2.3	6.4	2.5	3.9	1.5	0.1	30.1	0.7	1.0	1.2	1.3	0.7	1.1	1.7	0.3	1.5	4.0	0.0	0.8	0.4	0.3	2.3	3.3	0.7	3.7	4.1	1.0	1.0	0.5	0.6	1.4	0.0	0.0	2.2	2.7	6.2	0.0	0.0	0.7	0.4	0.7	2.5	3.3	2.0	4.2	8.7	18.4	0.0	0.9	0.5	0.7	1.4	1.9	1.6	38.0	3.2	0.7	3.2	2.9
C2CD2	"C21orf25, C21orf258, DKFZP586F0422, TMEM24L"	ENSG00000157617	"C2 calcium dependent domain containing 2"	Q9Y426	21	41885112-41954018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 51.6;Cone photoreceptor cells: 83.4;Granulosa cells: 100.0;Theca cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.1;SK-BR-3: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030922, HPA030924"	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030922: AB_2673660, HPA030924: AB_10669873"	"unprognostic (3.02e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.48e-1)"	39.9	126.3	18.6	8.3	18.0	1.3	23.3	18.4	19.8	12.0	16.9	12.9	4.9	8.3	8.4	10.7	9.4	8.3	7.5	16.4	18.6	10.1	8.6	7.9	9.7	21.8	20.9	18.9	11.3	29.2	7.2	5.2	20.2	17.3	5.8	24.6	10.8	11.5	2.8	15.6	9.0	7.8	20.5	41.4	11.7	3.3	23.4	6.7	8.5	4.1	7.9	12.8	11.4	26.1	13.4	5.5	3.9	8.9	79.1	21.7	15.1	9.3	14.4	5.7	5.2	8.7	15.0	0.2	5.0	18.0	14.0	1.5	13.9	9.7	7.2	0.9	6.2	2.3	7.1	7.1	10.6	1.0	0.0	14.0	8.9	30.3	11.7	12.5	27.1	0.7	8.4	0.1	15.3	1.2	1.9	2.7	21.4	5.7	18.7	1.4	5.7	8.0	8.5	27.8	6.3	2.8	10.1	44.6	8.1	7.6	11.7	5.9	9.3	13.5	1.9	4.5	7.6	5.0	7.9	1.1	39.2	7.7	2.8	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.1	0.5	0.3	0.1	0.3	0.1	0.0	0.3	0.1	18.6	18.0	18.4	19.8	16.4	18.6	21.8	20.9	20.2	20.5	23.4	26.1	24.8	3.2	15.5	20.5	4.4	4.1	9.1	7.6	15.9	51.6	8.2	7.0	3.1	8.6	8.3	3.7	83.4	12.8	4.4	3.4	0.0	5.6	0.3	6.0	6.7	19.3	4.9	5.9	20.3	8.5	4.8	11.9	17.9	8.3	0.0	100.0	46.1	5.2	3.6	1.7	14.4	6.9	6.1	7.0	10.5	0.2	3.7	5.6	1.8	24.4	2.5	3.6	3.1	11.6	18.8	8.1	5.0	2.2	8.1	15.9	3.0	2.5	7.7	36.9	13.1	7.4	17.9	0.1	3.0	14.3	2.6	9.3	2.8	82.4	6.9	16.6
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 3060.6"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	3.9	0.5	0.0	0.0	0.0	0.1	41.2	0.0	0.0	94.0	0.0	0.8	0.0	0.3	0.7	67.5	0.1	0.0	1.3	0.0	0.0	0.3	1.7	0.8	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	554.0	0.0	11.7	3060.6	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.2	0.6	0.0	13.4	0.1	306.6	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CCDC120	JM11	ENSG00000147144	"Coiled-coil domain containing 120"	Q96HB5	X	49053572-49069857	"Cancer-related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 29.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.9;BEWO: 28.6;HaCaT: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000561			Uncertain	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000561: AB_2244190"	"unprognostic (1.65e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.34e-3)"	3.1	2.6	5.2	2.1	5.0	2.3	4.4	7.6	6.4	10.6	4.5	5.2	8.7	4.4	5.7	35.9	5.0	2.5	1.8	5.0	4.8	9.1	6.6	4.3	2.0	3.9	4.0	6.3	8.0	3.8	9.3	4.0	3.9	7.7	2.2	2.0	12.0	4.0	0.7	29.3	7.4	1.6	3.0	3.8	6.8	3.4	4.9	2.9	6.0	0.5	3.9	5.3	16.1	3.5	20.9	2.8	4.5	0.2	0.0	0.0	28.6	0.7	1.0	1.5	2.4	6.9	8.7	0.8	3.2	1.2	3.4	19.5	3.4	11.7	0.1	5.4	6.6	2.0	5.0	2.4	1.5	0.1	3.4	2.5	9.0	1.9	0.5	3.1	2.5	5.4	2.9	0.2	0.0	17.5	7.5	0.5	5.1	9.8	0.1	6.6	3.3	2.0	8.8	11.0	6.0	4.7	3.6	7.2	2.2	6.1	17.7	2.8	1.2	0.1	5.2	0.2	0.2	6.6	4.8	0.1	0.2	0.1	0.9	1.1	0.2	0.5	0.3	0.0	0.2	0.2	0.4	0.3	0.0	0.6	0.4	0.3	1.0	0.4	0.1	0.6	0.1	0.1	5.2	5.0	7.6	6.4	5.0	4.8	3.9	4.0	3.9	3.0	4.9	3.5	1.7	6.4	3.1	2.0	2.5	5.1	3.5	7.1	4.0	6.8	8.2	5.6	1.3	4.3	6.0	12.9	4.2	12.7	2.2	5.6	0.0	5.1	0.1	8.5	2.2	2.7	6.0	1.7	4.8	6.5	3.2	2.9	9.7	11.5	0.0	4.9	2.5	2.5	2.3	10.1	6.2	6.2	2.0	1.2	1.5	0.5	2.1	0.9	0.0	2.8	0.4	3.3	2.1	2.5	0.7	14.4	8.3	1.2	1.5	6.3	9.0	3.1	5.0	6.8	0.0	2.6	1.5	1.4	2.4	9.0	9.2	16.8	2.3	2.3	4.6	11.4
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832690	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 305.0;urinary bladder: 303.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	2.6	0.4	0.1	23.0	0.0	0.2	69.0	0.8	0.3	61.2	4.8	256.3	126.9	26.7	24.4	305.0	75.8	48.9	0.4	0.2	0.0	116.2	4.8	64.0	1.0	0.4	1.5	1.2	116.2	51.9	13.1	36.3	0.3	82.2	123.3	0.3	204.6	39.1	0.5	180.8	190.6	7.3	0.0	0.7	13.3	0.6	0.2	10.7	111.7	0.3	37.5	303.5	105.7	0.0	358.1	4.4	0.0	1.5	0.0	0.4	395.0	3.3	0.2	0.3	0.4	184.9	761.4	0.6	28.0	0.1	2.6	193.3	0.0	0.5	0.4	0.7	0.4	0.2	20.3	127.0	0.1	0.1	0.9	0.0	1.9	0.1	0.4	0.3	0.0	0.2	0.3	0.7	0.0	400.2	0.7	1.9	0.7	402.0	495.0	0.5	6.9	7.6	92.4	340.2	79.5	1.7	0.4	636.8	0.8	21.6	250.9	0.9	0.5	0.9	13.7	3.1	3.5	0.9	0.7	0.7	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.2	0.0	0.4	1.5	0.3	0.0	0.2	0.0	5.1	275.7	230.2	0.0	12.2	16.2	3149.1	641.6	31.3	0.4	1255.2	548.4	0.8	287.4	954.3	218.8	0.0	771.7	18.7	1985.0	13.7	1026.1	0.0	1201.7	231.0	41.3	675.5	0.0	0.2	447.1	739.7	27.0	94.8	2298.8	27.3	0.2	0.4	0.5	76.3	0.0	0.1	1266.9	905.3	0.6	8.6	0.0	2.5	29.3	14.2	0.0	15.6	0.8	0.0	0.0	0.0	950.2	2081.0	0.0	2.5	2184.8	1906.1	21.6	635.6	0.0	0.0	0.1	68.2	0.0	0.2	1068.1	54.0	956.1	40.7	0.1	965.1	8033.4
CLN8	"C8orf61, EPMR, FLJ39417, TLCD6"	ENSG00000182372	"CLN8 transmembrane ER and ERGIC protein"	Q9UBY8	8	1755778-1801711	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 136.8;Syncytiotrophoblasts: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 76.7"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 76.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (5.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.36e-8)"	"unprognostic (1.36e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.24e-2)"	"unprognostic (8.38e-2)"	5.4	5.2	11.4	3.7	15.7	9.1	4.3	14.6	12.4	4.7	6.6	4.9	5.0	3.2	11.2	9.8	3.3	7.5	6.2	10.6	11.3	6.2	8.9	8.9	6.5	18.2	15.2	2.5	10.1	8.0	3.5	6.0	18.5	3.8	4.4	3.8	5.1	3.6	5.9	13.2	6.3	4.0	16.9	7.9	6.8	5.9	15.1	3.2	5.1	3.3	7.2	4.4	5.8	24.3	3.6	8.5	6.2	6.5	8.3	8.4	14.8	8.3	5.1	4.2	5.2	8.6	10.0	4.4	2.3	8.2	5.6	13.7	4.9	15.6	8.6	3.3	3.6	4.4	3.2	4.9	4.7	3.7	19.1	8.4	12.2	5.8	4.1	10.1	9.2	3.2	6.0	2.6	13.1	9.0	6.0	3.2	6.1	14.0	7.3	4.2	4.3	3.4	7.8	15.4	3.2	3.9	3.5	8.1	4.6	12.7	16.2	4.2	17.3	11.3	3.2	0.9	5.2	1.5	5.4	5.0	11.4	7.3	16.9	7.4	10.6	4.7	6.4	13.6	7.1	10.3	6.9	4.5	10.6	14.0	6.7	4.4	3.7	5.1	12.5	76.7	8.0	6.4	11.4	15.7	14.6	12.4	10.6	11.3	18.2	15.2	18.5	16.9	15.1	24.3	18.3	9.6	17.5	6.2	30.1	54.7	71.6	38.6	26.7	27.6	23.4	13.2	7.7	20.0	37.2	31.3	31.3	38.0	115.3	28.5	15.6	27.2	5.4	20.5	6.9	34.7	19.7	40.8	7.4	19.0	18.0	32.7	13.7	37.2	27.3	17.1	27.8	28.5	44.1	40.4	7.6	17.5	50.8	54.6	136.8	5.9	8.1	69.8	21.4	8.4	22.3	13.9	23.7	10.1	27.1	19.3	20.7	12.0	9.1	76.5	19.5	10.6	27.1	26.1	13.1	22.5	16.8	34.4	23.5	20.1	63.5	131.6	22.0	16.1	15.4	61.2
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390297	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 952.0;esophagus: 3093.3;vagina: 1442.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"memory B-cell: 61.2;naive B-cell: 70.2"	"Lineage enriched"	"Detected in many"	12	"B-cells: 70.2"	"Cell line enhanced"	"Detected in many"		"A549: 18.1;HEK 293: 25.7;MCF7: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favorable (4.02e-5)"	"unprognostic (2.45e-1)"	4.3	5.3	1.8	0.4	4.2	0.6	12.9	1.9	2.2	952.0	1.3	3.2	0.4	1.5	7.3	3093.3	1.6	0.1	1.9	1.9	2.8	2.3	1.4	0.9	0.7	2.1	1.9	1.0	3.3	1.6	2.2	0.1	1.7	8.6	1.3	0.1	661.6	1.1	1.7	555.6	3.5	0.5	1.7	3.3	3.3	2.4	2.9	2.8	1.8	0.0	276.8	2.4	1442.7	1.6	6.0	18.1	0.4	1.6	0.8	0.9	0.2	1.0	0.3	0.4	0.4	1.0	1.6	5.1	8.0	0.2	1.2	2.4	1.5	2.3	0.1	0.0	25.7	0.4	6.9	1.9	0.0	0.0	0.1	1.8	4.0	1.0	0.0	0.1	0.0	4.7	1.1	0.2	0.0	12.6	0.1	0.1	6.6	8.1	5.4	2.2	0.3	2.9	1.6	2.3	2.7	7.7	3.4	5.1	2.5	2.7	6.2	2.6	0.0	0.0	5.3	0.2	0.1	5.8	7.6	3.6	0.1	2.2	0.3	0.1	4.6	0.1	1.7	3.9	0.4	61.2	1.3	1.2	5.9	70.2	0.6	0.9	1.3	0.0	0.9	1.3	0.1	2.2	1.8	4.2	1.9	2.2	1.9	2.8	2.1	1.9	1.7	1.7	2.9	1.6	32.7	3.2	2.2	0.0	24.6	4.6	16.8	28.5	14.8	0.1	57.9	51.6	0.8	2.8	20.2	33.1	0.0	0.2	2.1	24.5	7.9	13.1	1.5	20.6	3.9	9.3	32.5	3.6	0.1	2.5	0.3	2.3	4.6	23.9	4.5	7.2	3.9	0.7	5.7	0.0	0.2	33.4	14.2	3.8	7.7	3.9	5.3	6.3	3.6	0.0	6.4	0.3	7.2	0.0	0.1	2.4	39.4	4.5	0.5	11.5	43.8	12.3	10.5	0.1	0.0	0.9	8.0	0.4	17.4	71.8	12.9	0.3	1.3	1.1	41.8	27.0
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192637	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.2;Proximal enterocytes: 93.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 11.4;monocytes: 7.8;T-cells: 11.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 66.6;OE19: 56.4;SK-BR-3: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.9	1.7	1.9	4.9	1.5	14.8	4.7	4.9	3.2	6.1	0.0	17.5	34.3	1.6	0.7	15.2	4.7	18.2	0.3	1.2	2.9	1.1	3.3	7.4	2.9	3.7	3.4	0.3	0.4	2.5	4.0	2.1	4.9	14.3	12.9	1.2	6.1	1.4	0.3	9.3	35.1	2.2	0.8	3.0	11.1	9.2	4.5	5.7	1.2	0.3	5.9	12.8	7.7	1.8	8.4	2.9	0.6	2.0	1.2	1.3	66.6	0.6	0.7	2.1	3.2	19.1	1.4	0.1	9.4	1.2	3.2	23.1	7.7	12.7	1.3	6.9	1.8	0.2	11.6	17.1	2.7	7.9	0.7	0.4	15.4	1.0	18.6	0.7	0.7	10.0	6.8	3.8	0.3	6.3	1.5	7.8	8.6	56.4	2.2	6.1	0.1	0.2	1.3	23.5	1.7	2.4	4.4	45.3	1.6	15.0	5.3	12.8	0.6	0.2	9.7	0.2	2.4	0.7	4.0	0.7	0.5	2.5	2.8	11.2	1.4	11.4	2.4	2.9	5.2	0.6	3.9	3.7	0.5	0.5	2.5	3.3	1.0	1.7	7.8	0.7	11.9	1.5	1.9	1.5	4.9	3.2	1.2	2.9	3.7	3.4	4.9	0.8	4.5	1.8	2.8	12.8	27.8	0.7	3.1	6.6	18.9	47.2	14.8	2.1	8.5	4.3	1.9	28.6	46.4	0.0	4.2	10.5	2.1	76.2	0.0	4.5	2.6	15.6	11.6	6.0	7.2	0.8	11.6	5.1	42.2	2.2	36.2	19.9	0.0	38.1	0.7	3.8	6.0	1.7	10.5	15.7	20.3	12.0	2.6	3.9	0.0	10.6	0.0	1.0	1.8	0.7	2.1	0.5	0.8	22.6	19.7	0.4	1.4	15.7	93.0	1.7	35.8	1.7	0.0	1.5	3.7	0.5	3.3	29.4	9.9	15.9	10.7	0.2	36.3	30.4
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508525-15552317	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.8;skin 1: 58.6;vagina: 22.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.8;Breast myoepithelial cells: 5.5;granulocytes: 7.0;Prostatic glandular cells: 4.0;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.1;MAIT T-cell: 4.3;non-classical monocyte: 14.1"	"Group enriched"	"Detected in many"	8	"monocytes: 14.1;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.7;T-47d: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"			"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	10.5	0.0	0.0	0.2	0.3	0.0	18.8	0.1	0.1	0.0	0.0	0.0	0.0	7.0	0.3	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	3.2	6.4	0.2	58.6	0.1	0.0	0.0	0.3	1.4	1.0	0.0	0.1	0.0	0.0	1.7	6.3	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	6.1	4.3	0.0	0.5	1.5	0.2	0.0	0.0	0.4	0.0	1.1	14.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	8.8	5.5	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	3.0	0.0	1.8	0.0	0.0	0.3
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	476.0	5.1	5.8	19.4	11.7	7.2	133.6	2.9	6.1	2.6	5.3	9.0	14.5	1.2	1.8	24.1	2.1	5.8	11.7	5.7	6.4	3.4	331.8	5.6	4.0	3.7	3.9	1.8	4.6	2.1	1.6	1.5	5.5	2.2	4.9	0.6	10.5	1.6	4.1	151.5	16.5	2.8	3.4	15.0	12.8	38.1	6.9	4.3	8.8	5.6	18.2	21.3	12.6	5.1	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.8	11.7	2.9	6.1	5.7	6.4	3.7	3.9	5.5	3.4	6.9	5.1	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005553-97011040	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory bulb: 27.0"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.4	0.0	2.1	0.0	7.3	0.3	0.1	0.0	4.3	2.0	0.0	0.2	0.0	2.5	0.8	0.0	0.4	0.0	0.1	0.8	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	3.0	0.0	0.3	0.0	0.0	1.1	0.9	0.1	1.5	0.0	0.2	0.0	0.1	0.0	5.5	1.2	0.3	0.4	0.1	0.2	0.3	0.2	0.4	0.0	0.0	0.0	10.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	1.9	15.3	0.0	0.0	0.0	3.9	0.0	5.9	7.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	2.6	1.6	0.0	0.0	0.0	0.0	2.2	7.3	11.0	1.0	0.0	0.3	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.9	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	7.3	0.0	4.3	0.8	4.7	0.0	0.0	0.0	0.0	1.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	32.9	0.1	0.0	0.0	0.0	22.6	37.3	2.2	0.2	0.0	0.0	0.0	0.0	70.4	0.2	0.0	27.5	0.0	0.0	0.0	0.0	3.3	0.0	8.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.8	6.8	10.2	0.0	0.0	17.4	0.3	0.0	0.0	0.1
DYNLRB1	"DNCL2A, DNLC2A, ROBLD1"	ENSG00000125971	"Dynein light chain roadblock-type 1"	Q9NP97	20	34516414-34540958	"Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009845	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB009845: AB_2093671"	"unprognostic (2.23e-1)"	"unprognostic (7.60e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (9.10e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.00e-1)"	168.7	208.4	430.4	96.9	440.2	113.7	163.7	416.5	552.8	163.7	400.8	228.4	113.8	193.0	204.9	155.4	198.5	117.1	275.7	448.5	454.1	265.8	122.0	169.4	123.9	444.7	443.3	153.9	115.0	222.9	204.3	154.6	436.7	180.9	128.2	171.7	142.1	170.7	222.8	222.1	156.4	158.7	416.1	143.0	166.7	66.6	422.8	154.3	174.4	224.5	135.1	191.4	158.8	458.8	244.4	317.6	259.4	207.3	307.5	294.9	175.4	264.1	393.5	399.2	340.7	853.3	231.1	135.6	327.4	402.0	385.5	215.3	282.2	391.6	265.9	164.5	198.8	463.2	286.8	679.1	345.7	217.5	249.6	251.4	250.4	320.2	245.7	306.2	282.2	255.8	195.1	249.0	415.5	313.4	314.7	427.4	148.6	284.7	345.2	158.6	359.6	220.2	618.7	160.8	264.2	273.9	382.9	631.9	359.4	249.2	362.5	240.7	251.9	500.8	122.4	351.2	295.8	208.8	310.3	157.3	430.1	186.7	225.0	225.4	112.5	221.2	88.0	123.1	88.8	144.2	145.6	117.2	128.8	127.3	101.4	102.1	111.4	132.4	144.3	161.2	238.7	135.0	430.4	440.2	416.5	552.8	448.5	454.1	444.7	443.3	436.7	416.1	422.8	458.8	188.4	169.9	106.5	26.1	107.9	146.8	176.8	215.9	100.2	105.4	136.0	200.3	125.5	170.1	157.4	292.4	58.4	297.8	112.9	283.9	481.3	264.4	34.0	266.4	139.5	170.9	226.7	98.2	34.7	223.4	211.4	149.1	85.1	208.5	159.0	149.8	162.4	104.1	287.9	80.8	30.0	284.6	256.3	127.8	131.5	51.0	234.9	139.1	193.9	19.7	236.2	435.8	148.3	20.1	61.4	317.5	379.3	240.3	117.0	240.4	388.9	781.8	253.1	127.6	203.8	101.8	210.8	65.6	77.2	106.3	150.0	342.3	124.9	90.9	160.5	184.3
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174231-74197122	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 990.0;Late spermatids: 2765.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		750000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	186.9	174.9	151.0	117.8	159.3	283.3	168.3	163.8	157.3	179.8	129.6	208.4	130.2	186.4	76.6	249.3	163.6	100.0	171.0	149.9	151.9	156.6	197.0	158.4	130.3	161.9	156.9	181.2	226.4	160.7	119.9	162.8	162.2	150.3	100.2	149.8	170.1	125.1	399.8	230.9	148.9	119.2	165.2	137.4	192.9	79.9	164.6	150.2	141.2	173.4	137.2	175.3	179.7	187.1	526.3	341.4	251.3	303.1	220.8	231.8	283.4	359.8	276.3	300.3	289.5	423.3	388.6	444.3	96.6	338.8	424.2	266.6	280.5	481.5	286.3	298.0	329.2	247.5	305.2	345.9	253.1	429.0	236.9	273.2	300.8	326.2	460.7	341.5	326.8	260.1	445.8	186.4	305.2	448.2	342.0	516.8	337.6	430.3	328.9	386.9	342.7	401.5	250.9	324.7	252.7	325.4	340.9	420.3	296.0	331.3	476.8	272.4	340.2	411.6	284.6	345.1	474.4	218.8	299.8	771.4	326.3	435.1	441.4	213.7	229.7	245.6	156.9	255.6	164.5	146.4	161.4	158.3	224.2	132.9	183.9	151.7	150.1	193.5	270.2	95.1	194.7	388.0	151.0	159.3	163.8	157.3	149.9	151.9	161.9	156.9	162.2	165.2	164.6	187.1	105.8	83.3	81.2	15.7	97.1	119.2	153.8	101.5	78.0	93.1	103.0	95.5	43.3	68.6	68.7	44.1	25.0	198.8	91.9	98.7	107.6	148.1	990.0	104.8	98.3	103.0	90.4	79.5	25.3	157.7	381.4	101.6	61.2	112.5	122.4	112.1	79.6	95.7	124.2	97.6	24.6	87.2	91.6	101.2	102.7	2765.8	103.8	86.8	72.9	15.9	157.4	134.7	119.4	16.6	44.2	147.0	82.8	110.6	82.7	140.7	84.6	69.0	57.8	72.3	85.5	107.3	117.7	61.2	64.6	90.1	116.1	395.3	92.4	116.9	109.5	140.4
ELOVL7	FLJ23563	ENSG00000164181	"ELOVL fatty acid elongase 7"	A1L3X0	5	60751791-60844274	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 190.2;Oligodendrocytes: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.9;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 41.9;HDLM-2: 29.3;HEL: 37.3"	"Low region specificity"	"Detected in all"							HPA036337	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA036337: AB_10670797"	"unprognostic (6.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.54e-9)"	"unprognostic (6.95e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.30e-3)"	10.5	5.5	23.1	2.2	24.9	1.0	22.1	29.5	26.5	3.6	36.2	8.8	11.8	2.2	0.9	5.0	2.8	19.3	0.9	18.3	30.0	16.2	1.0	3.8	2.5	31.8	26.3	0.5	8.5	21.0	2.7	0.8	32.9	22.0	11.5	10.5	4.7	1.2	0.5	26.2	21.3	3.7	30.1	0.5	3.3	0.8	32.9	1.8	16.8	1.0	4.0	7.6	6.7	32.2	20.7	7.6	0.1	0.5	0.0	0.0	18.6	0.0	4.3	2.5	8.4	9.6	21.4	0.0	9.1	0.0	41.9	1.2	11.9	8.3	3.8	29.3	6.9	37.3	0.9	3.2	0.2	3.0	15.2	0.1	14.6	0.3	12.3	0.9	0.0	6.5	5.9	7.2	0.0	17.8	0.1	0.3	2.4	1.9	0.1	1.6	1.9	1.2	19.4	18.5	7.8	1.2	10.9	8.8	5.0	2.0	14.2	0.6	0.2	1.5	9.0	0.2	7.2	18.5	19.7	0.3	13.2	0.8	0.4	1.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.5	23.1	24.9	29.5	26.5	18.3	30.0	31.8	26.3	32.9	30.1	32.9	32.2	14.5	12.8	3.1	4.9	0.5	31.1	13.1	1.4	4.6	2.3	3.1	1.4	0.7	20.0	4.8	12.9	0.0	0.2	0.3	8.8	5.9	6.8	0.1	6.5	1.6	21.1	4.8	1.3	29.5	3.1	0.0	2.0	5.6	20.4	12.7	0.4	0.4	0.0	0.1	0.0	26.0	17.0	0.0	0.0	16.6	0.0	0.0	4.9	10.6	190.2	2.0	3.5	0.0	6.0	90.8	7.1	13.3	0.0	0.1	23.4	29.7	8.9	1.7	6.7	0.0	1.0	0.8	0.2	1.1	2.9	38.2	2.9	0.9	0.2	15.9	8.6
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.3;skin 1: 67.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 77.8;Basal squamous epithelial cells: 39.3;Distal enterocytes: 46.5;Squamous epithelial cells: 55.3;Suprabasal keratinocytes: 68.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	2.3	2.2	0.8	2.9	0.8	1.4	2.8	0.8	1.2	10.8	2.1	8.2	10.8	2.5	0.9	51.3	1.6	6.4	17.2	0.8	1.9	7.1	21.7	3.2	3.0	1.6	1.4	1.4	9.5	6.4	4.3	0.7	2.7	3.5	5.3	0.2	10.9	2.2	6.9	67.3	11.3	1.5	0.9	2.0	9.8	1.0	1.4	3.7	5.6	0.8	5.7	2.5	17.0	0.7	24.7	22.4	0.2	0.0	0.7	2.0	35.9	25.2	11.0	21.0	15.7	28.7	8.8	16.1	15.1	16.7	17.1	28.6	3.6	21.1	9.6	13.2	8.1	0.4	11.2	15.9	15.3	2.9	7.9	2.8	38.9	13.6	22.3	7.9	7.6	2.5	7.7	0.5	6.0	15.0	0.7	6.0	11.0	34.1	0.1	0.1	0.0	7.8	10.1	6.2	11.2	0.0	8.7	5.3	1.5	29.1	9.2	3.6	14.2	12.9	21.6	6.1	29.8	2.2	4.0	4.1	10.1	0.1	8.6	1.1	0.0	0.0	0.7	0.0	0.3	0.3	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.8	0.8	0.8	1.2	0.8	1.9	1.6	1.4	2.7	0.9	1.4	0.7	0.6	3.2	2.2	0.0	2.5	77.8	12.2	9.9	39.3	0.2	7.1	2.9	5.1	11.5	6.3	7.3	0.0	0.4	0.7	46.5	0.0	15.8	0.1	2.4	1.0	1.9	7.1	2.7	0.1	10.0	9.7	2.6	17.3	5.0	8.9	3.5	1.1	20.9	1.2	0.0	0.1	17.7	8.2	0.3	7.8	1.9	0.0	1.0	5.4	0.0	1.0	0.2	3.1	0.5	0.0	24.3	22.8	0.0	3.0	13.2	15.3	4.4	2.5	0.4	0.0	1.3	2.0	0.1	1.0	55.3	68.5	1.9	2.6	0.0	17.1	9.1
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 716.7;skin 1: 1439.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8"	"Cancer enhanced"	"Detected in many"		"glioma: 43.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 518.2;NK-cell: 781.6"	"Group enriched"	"Detected in all"	15	"NK-cells: 781.6;T-cells: 518.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	9.5	33.7	212.8	27.7	235.6	12.1	112.2	215.4	322.0	250.1	239.2	30.5	17.2	19.1	541.4	716.7	10.5	35.1	48.8	237.4	212.0	24.0	2.9	372.8	18.4	237.6	211.6	9.4	5.3	13.3	11.7	59.6	218.5	26.9	7.0	22.1	172.0	64.7	19.2	1439.9	11.3	115.6	238.8	11.9	33.9	45.3	215.0	15.8	224.5	31.8	190.4	34.1	368.6	234.2	0.0	0.0	0.0	0.0	5.0	15.7	5.9	0.0	0.0	1.4	1.0	0.0	0.0	12.6	0.7	0.3	2.3	2.2	1.4	0.0	1.9	31.2	0.2	0.1	0.0	0.0	2.0	0.0	0.1	2.6	11.9	3.6	0.0	3.4	66.9	0.0	0.0	0.5	3.2	0.5	0.1	1.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	50.5	1.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	76.2	0.0	0.2	0.5	0.1	26.0	0.1	0.1	3.2	0.0	0.0	5.7	1.1	2.0	518.2	3.5	282.0	43.4	123.6	227.6	2.6	36.5	20.9	150.8	11.2	781.6	4.5	3.6	9.1	365.6	212.8	235.6	215.4	322.0	237.4	212.0	237.6	211.6	218.5	238.8	215.0	234.2	14.5	750.0	569.2	38.2	23.3	414.6	42.2	8.7	59.7	3.5	3.4	3.0	14.8	2.8	125.6	1.8	0.0	2.3	345.3	0.8	1.9	0.4	33.3	2.8	4.0	28.7	8.4	30.5	62.2	0.2	5.5	16.7	5.6	5.2	10.1	99.5	5.3	1.2	4.0	0.0	7.9	11.1	4.1	11.4	30.9	45.9	3.1	7.9	35.6	14.0	41.4	166.4	1150.4	7.1	6.7	1.7	0.0	3.0	9.6	31.3	1.2	0.6	12.5	5.6	32.9	3.7	104.8	3.3	15.3	31.6	377.2	321.8	219.9	0.1	1.4	28.8
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	NA	NA		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	6.7	10.1	3.4	2.8	3.6	3.5	6.1	3.7	4.2	8.1	5.9	8.6	3.3	7.4	9.7	9.8	6.5	2.9	11.7	3.4	3.7	5.9	11.4	5.9	3.4	3.8	3.7	5.4	12.3	9.5	4.7	2.7	3.9	9.1	3.8	10.3	7.8	4.2	28.8	36.4	6.8	3.7	3.6	6.3	8.2	25.8	3.6	2.4	6.7	9.7	4.1	8.9	7.9	3.8	12.1	22.9	6.2	15.1	10.5	5.8	8.5	10.4	13.3	6.1	5.2	19.4	9.5	12.5	16.4	14.3	7.2	16.3	14.6	10.0	3.9	14.7	8.8	5.1	13.7	25.9	11.5	14.9	6.5	5.4	6.6	9.1	14.0	7.8	8.6	3.3	10.0	8.1	5.4	18.0	6.6	8.8	10.2	10.4	5.2	10.2	10.8	9.0	10.9	19.3	2.2	5.6	14.3	6.4	6.7	6.8	12.6	6.3	15.3	4.4	8.2	5.0	10.4	11.2	12.2	14.5	6.9	10.9	4.4	0.3	3.5	1.4	2.0	4.2	2.2	2.9	2.6	2.9	4.6	2.1	1.9	2.0	0.0	3.7	5.9	1.3	3.9	2.3	3.4	3.6	3.7	4.2	3.4	3.7	3.8	3.7	3.9	3.6	3.6	3.8	12.9	9.6	14.1	20.9	11.1	5.2	6.1	10.5	5.2	15.0	8.7	4.3	45.7	7.2	10.6	7.3	47.9	11.2	10.0	14.0	1.9	14.0	46.4	14.9	19.3	10.8	10.8	19.6	43.3	20.2	5.7	9.1	22.4	16.5	1.3	9.9	11.7	24.1	11.9	6.7	42.6	12.7	18.3	16.6	5.4	12.0	6.5	12.5	8.8	23.4	7.8	7.8	4.1	20.6	24.0	16.5	5.7	10.1	24.2	12.2	9.0	10.7	23.3	26.9	6.6	7.6	13.2	51.5	11.0	19.6	16.3	3.8	8.5	9.8	9.8	9.6
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985658	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 14.3;lymphoid tissue: 39.4;skin 1: 31.3"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 136.0;Club cells: 36.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;HaCaT: 1.0"	"Not detected"	"Not detected"							HPA068168			Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		11000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA068168: "	"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.9	0.2	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	39.4	0.8	3.6	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	136.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	1.3	0.2	0.0	1.7	13.2	0.0	0.0	0.0	0.0	7.8
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.2;Excitatory neurons: 53.5;Inhibitory neurons: 53.3;Late spermatids: 199.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 25.8;monocytes: 23.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		67000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.4	11.3	23.5	9.9	35.8	17.1	2.5	35.8	63.3	7.7	0.0	11.0	4.6	5.2	2.7	7.7	3.3	4.7	4.6	41.2	3.3	3.6	2.5	7.5	5.9	12.1	2.6	2.7	15.2	4.1	32.6	3.9	2.6	9.2	6.1	9.2	6.9	4.8	10.2	10.6	6.8	5.6	0.8	8.2	10.8	5.8	2.8	2.8	2.4	3.7	6.6	14.9	6.4	27.4	6.7	7.1	4.7	6.8	8.6	6.4	1.2	6.6	10.4	9.2	5.3	3.2	3.1	2.2	2.8	8.0	5.6	5.8	4.4	10.5	5.7	4.9	3.6	4.3	1.9	1.7	4.1	0.5	5.9	11.9	5.5	10.6	1.4	3.9	5.0	4.6	19.1	5.4	8.3	10.5	0.8	1.8	4.6	7.8	5.6	0.8	6.0	1.4	8.7	4.8	13.7	2.1	7.7	12.7	3.1	4.7	10.3	1.3	10.0	5.7	4.3	8.7	2.3	8.4	1.6	4.8	7.5	3.3	6.2	24.6	11.1	17.9	1.4	13.4	0.4	0.0	0.9	0.9	4.1	0.1	0.8	0.9	25.8	1.3	23.9	5.9	0.3	5.3	23.5	35.8	35.8	63.3	41.2	3.3	12.1	2.6	2.6	0.8	2.8	27.4	0.9	6.4	5.8	7.5	2.6	4.0	7.8	12.4	2.2	17.9	2.7	1.1	8.3	2.8	15.3	1.8	6.2	0.6	8.0	16.0	0.0	2.8	50.2	2.8	7.5	3.3	11.4	0.4	53.5	4.7	0.8	6.9	10.7	4.9	2.5	1.7	3.3	2.9	6.9	48.8	53.3	8.6	10.2	21.5	4.6	199.5	16.1	30.9	3.6	11.2	24.5	3.1	3.1	8.5	7.0	9.1	7.2	26.7	16.5	15.0	4.8	1.8	23.9	5.4	0.0	5.4	3.4	4.1	4.1	1.2	4.4	3.4	4.6	4.8	5.2	29.8
MPZL3		ENSG00000160588	"Myelin protein zero like 3"	Q6UWV2	11	118226690-118252365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.3;skin 1: 30.4"	"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	6	"basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8"	"Group enriched"	"Detected in all"	8	"granulocytes: 99.4;T-cells: 28.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029116			Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA029116: AB_10610142"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.20e-1)"	3.3	0.5	0.7	4.7	1.0	7.3	8.2	2.8	0.7	11.5	1.7	5.6	5.4	1.5	4.9	33.3	5.4	7.6	1.6	0.7	0.8	3.1	7.5	7.9	4.8	1.0	0.7	0.5	7.2	6.7	3.8	0.8	0.9	5.6	6.1	1.3	11.7	2.7	1.7	30.4	5.3	1.5	0.7	6.0	6.8	1.1	0.8	2.8	6.1	0.9	12.6	4.4	16.8	0.7	5.0	0.6	0.0	0.7	0.0	0.0	0.7	0.6	0.1	0.1	0.1	16.7	26.3	4.9	12.5	0.0	1.9	6.8	1.2	5.6	0.1	0.3	2.0	3.0	1.4	8.1	0.2	4.1	29.0	0.3	13.6	0.0	5.4	0.0	8.8	3.3	3.8	2.7	0.1	17.1	1.9	2.2	2.4	16.5	1.2	0.0	0.0	7.4	10.0	6.2	3.4	0.3	6.6	8.6	0.5	1.3	15.4	2.2	4.3	0.1	1.3	0.1	0.1	0.4	5.1	3.1	0.1	0.1	0.3	44.3	6.0	99.4	7.0	3.7	28.9	1.7	11.3	9.6	8.1	1.9	8.4	6.9	87.8	8.2	2.6	1.1	8.4	5.3	0.7	1.0	2.8	0.7	0.7	0.8	1.0	0.7	0.9	0.7	0.8	0.7	2.4	16.0	26.9	0.0	4.9	35.6	21.7	11.8	9.6	0.3	28.2	14.7	1.7	5.7	15.9	9.2	2.1	0.6	9.6	19.6	0.0	10.5	7.4	32.7	4.1	4.9	12.0	0.4	2.2	8.8	0.7	1.6	18.3	34.0	1.3	0.1	2.2	8.2	1.3	0.0	2.3	5.1	14.2	5.1	18.7	7.7	0.0	5.5	10.6	1.9	3.8	0.3	4.1	0.5	0.3	16.7	9.1	0.4	6.6	30.6	9.3	1.1	43.8	1.7	0.0	0.4	2.3	1.7	0.8	14.3	63.9	1.6	44.3	0.2	8.1	46.4
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"OE19: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: AB_2676526"	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	7.0	6.4	2.9	5.5	2.9	9.7	6.2	3.5	3.8	12.9	3.2	6.5	3.5	5.7	1.0	31.7	5.9	5.3	6.2	2.8	3.1	3.6	3.6	8.8	4.8	3.7	3.1	4.9	6.1	4.4	5.7	2.9	3.2	5.1	3.6	1.6	14.4	0.9	12.3	11.8	6.2	2.0	2.8	6.8	5.6	3.4	3.4	5.4	6.5	7.2	4.8	6.8	13.6	3.7	7.3	11.0	1.7	5.4	8.4	4.8	0.1	3.3	4.9	1.9	2.6	4.2	6.0	5.2	3.4	3.9	14.1	1.7	4.1	1.9	1.6	13.7	3.5	0.0	5.6	6.9	2.0	0.0	4.3	2.2	4.9	0.9	8.0	3.8	10.0	0.0	5.2	6.2	9.1	6.0	5.2	1.1	1.7	26.6	9.0	2.8	5.6	5.3	6.0	16.8	3.2	2.1	3.2	4.5	5.2	4.8	10.1	5.3	19.1	12.7	3.6	5.2	5.9	0.6	6.2	1.8	7.7	2.8	5.8	2.8	1.2	1.0	0.2	0.3	0.0	1.2	0.6	0.2	0.3	0.3	0.2	0.0	6.5	0.7	0.4	0.2	0.5	0.2	2.9	2.9	3.5	3.8	2.8	3.1	3.7	3.1	3.2	2.8	3.4	3.7	12.6	12.8	18.1	7.8	17.5	18.0	18.1	10.3	6.8	10.4	11.7	8.4	8.7	15.7	12.7	12.9	16.7	4.8	24.3	25.6	5.9	8.1	4.3	24.9	11.1	12.1	13.8	10.8	13.5	8.2	4.7	12.1	19.9	27.9	1.3	5.4	12.8	8.1	9.1	16.8	13.3	13.0	4.1	27.9	15.2	2.0	7.2	21.1	7.2	9.4	13.7	7.3	14.4	7.5	20.8	18.3	17.7	7.9	22.9	27.2	8.6	10.5	11.9	8.2	0.0	17.7	7.6	7.6	3.7	10.0	16.3	8.6	18.5	9.3	12.2	43.1
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135727	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 245.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 403.5;Extravillous trophoblasts: 648.4;Paneth cells: 262.6;Proximal enterocytes: 358.0;Syncytiotrophoblasts: 450.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 243.7;CACO-2: 165.9;CAPAN-2: 111.9;hTCEpi: 157.8;OE19: 79.6;SK-BR-3: 186.3"	"Region enriched"	"Detected in single"	8	"hippocampal formation: 1.4"	"Low region specificity"	"Detected in single"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		4400000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.8	0.4	0.3	15.0	0.4	0.2	25.5	2.1	0.6	31.1	6.7	129.4	155.7	9.9	113.0	136.2	15.4	47.7	0.4	0.6	0.2	90.6	28.0	54.1	0.3	0.3	0.2	0.6	139.4	56.0	8.4	51.0	0.4	49.0	72.6	0.0	245.4	8.5	0.3	115.3	151.8	3.5	0.1	0.2	156.2	0.5	0.2	15.4	50.8	0.0	11.8	4.9	56.0	0.2	63.4	0.2	0.1	0.2	0.0	0.0	243.7	0.0	0.0	0.0	0.0	165.9	111.9	0.0	1.3	0.0	0.0	73.5	0.1	69.7	0.0	0.3	0.4	0.1	0.3	6.5	0.0	0.0	0.3	0.0	157.8	0.0	2.4	0.0	0.0	0.1	1.9	0.1	0.0	68.1	0.6	1.4	20.5	79.6	0.1	0.5	0.0	1.2	7.5	13.1	0.9	0.7	0.0	186.3	0.1	18.8	42.8	0.8	0.0	0.1	1.9	0.6	0.4	0.3	0.5	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.1	0.6	0.6	0.2	0.3	0.2	0.4	0.1	0.2	0.2	0.4	99.3	60.1	0.0	1.0	37.9	82.7	108.9	76.2	0.5	74.4	39.2	0.3	62.9	107.4	42.3	0.0	168.8	0.8	403.5	29.4	192.4	0.0	35.2	11.4	2.6	9.6	2.7	0.1	224.4	648.4	3.5	82.6	109.5	7.0	0.0	0.0	18.2	22.8	0.0	0.2	132.1	87.5	0.3	2.7	0.0	0.6	1.9	3.6	0.0	4.2	0.3	0.0	0.0	0.0	240.7	262.6	0.0	0.1	66.0	358.0	28.6	21.2	0.1	0.0	0.1	4.7	0.0	0.2	81.9	54.0	450.7	2.2	0.0	150.8	91.0
PTGER3	"EP3, lnc003875"	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047808	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 95.2;kidney: 81.2;smooth muscle: 68.0"	"Group enriched"	"Detected in many"	7	"Distal tubular cells: 225.0;Langerhans cells: 79.8"	"Group enriched"	"Detected in some"	7	"breast cancer: 4.1;renal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	59	"basophil: 43.3"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 43.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.6;HAP1: 20.9;HDLM-2: 32.8;HEL: 15.6;T-47d: 72.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA010689: AB_1855883"	"unprognostic (1.53e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-4)"	54.5	6.7	7.1	5.0	4.3	0.2	28.6	0.0	8.5	4.7	10.4	13.9	1.2	95.2	3.7	3.9	10.1	8.9	1.6	4.7	10.9	81.2	0.3	1.0	1.3	5.6	0.6	1.7	6.6	0.9	0.6	0.6	3.2	3.0	2.3	0.7	11.9	7.9	0.4	13.8	3.7	68.0	2.4	0.3	22.4	1.0	4.7	0.9	1.0	1.4	1.4	6.6	6.1	1.1	0.0	0.0	0.0	0.0	28.6	0.7	0.1	0.7	0.0	0.1	0.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	20.9	0.0	0.1	32.8	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.1	0.0	0.3	0.0	0.2	72.5	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	43.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	7.1	4.3	0.0	8.5	4.7	10.9	5.6	0.6	3.2	2.4	4.7	1.1	6.9	0.0	0.5	0.0	0.0	5.0	0.2	0.0	0.0	1.6	13.7	6.1	1.8	1.5	0.0	20.2	0.0	0.0	0.2	0.4	225.0	3.0	1.6	0.6	4.6	1.7	2.4	0.0	2.2	0.0	2.4	12.2	1.5	1.2	9.5	0.0	0.7	0.0	0.1	3.3	3.4	1.0	12.2	0.0	79.8	1.0	1.2	3.2	8.8	0.0	0.6	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.1	1.3	0.1	7.2	0.0	0.2	6.6	0.5	11.7	0.1	0.1	0.1	7.5	0.1	1.2	6.2	0.0	0.2
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 142.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 441.1;Inhibitory neurons: 416.6;Microglial cells: 142.4;Oligodendrocyte precursor cells: 303.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.5;SCLC-21H: 8.3;U-266/70: 11.0;U-266/84: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	5.3	45.6	105.0	1.8	113.1	0.2	6.8	69.8	141.6	6.1	49.1	2.1	2.4	5.6	3.1	2.6	3.4	4.7	7.5	142.3	77.7	5.3	34.6	11.4	2.0	61.2	75.0	13.1	4.5	4.0	6.2	2.6	60.8	4.1	1.6	18.8	2.4	3.3	1.5	14.9	2.3	5.4	55.7	0.6	7.7	4.7	128.3	2.2	5.5	1.7	2.0	5.3	3.2	121.9	0.1	0.2	3.2	0.5	0.1	0.3	0.1	1.1	0.7	0.1	0.3	0.0	3.7	0.0	0.2	0.0	0.2	0.7	2.8	0.7	0.3	0.2	5.9	0.6	2.8	0.0	0.0	3.2	0.9	0.1	0.9	0.0	0.0	3.2	3.5	1.6	0.0	21.5	0.1	0.1	0.2	0.2	0.4	1.8	0.4	0.1	0.7	0.0	0.0	6.6	8.3	3.0	0.1	0.1	1.1	1.6	0.1	0.1	1.0	0.1	0.3	0.0	0.3	11.0	23.0	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.0	113.1	69.8	141.6	142.3	77.7	61.2	75.0	60.8	55.7	128.3	121.9	14.7	3.2	2.8	23.2	1.9	6.1	1.1	0.1	2.8	3.5	5.5	3.9	6.9	0.0	0.0	0.0	45.9	0.1	0.1	0.0	0.0	1.7	2.5	1.2	0.2	32.4	7.8	0.0	441.1	2.7	0.1	4.8	3.1	0.9	0.0	3.3	23.9	11.8	0.1	1.7	416.6	0.5	0.0	1.2	2.1	1.4	4.4	0.2	3.6	142.4	0.0	1.3	0.0	303.1	28.4	1.5	0.1	1.5	1.6	0.5	0.0	0.0	0.0	9.2	0.0	0.4	1.2	0.7	4.1	1.6	3.8	0.1	0.6	4.2	0.1	0.7
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RMND5B	"FLJ22318, GID2, GID2B"	ENSG00000145916	"Required for meiotic nuclear division 5 homolog B"	Q96G75	5	178130996-178150568	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 186.6;Late spermatids: 415.4;Spermatocytes: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 130.3;MCF7: 185.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047778	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA047778: AB_2680153"	"unprognostic (2.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (7.66e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.22e-8)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.43e-2)"	"unprognostic (5.78e-2)"	18.9	23.4	19.8	11.2	19.7	13.2	18.8	19.2	20.3	24.0	19.4	24.5	13.2	22.7	12.2	69.8	19.2	9.6	28.1	19.7	18.7	22.4	27.2	17.4	18.0	22.3	19.4	17.1	25.4	23.5	20.7	16.4	19.1	19.0	11.4	10.5	24.2	15.9	45.6	29.6	17.3	15.9	19.6	19.2	23.2	81.6	21.2	23.7	20.5	32.4	23.0	22.1	28.2	20.9	21.3	37.5	21.4	53.5	27.4	2.8	71.3	16.9	18.2	25.1	29.2	42.1	30.2	44.6	32.9	11.9	27.6	27.6	21.5	36.7	8.8	130.3	28.7	46.8	39.1	22.8	29.0	21.9	16.3	5.9	27.1	17.3	27.3	14.0	25.5	14.7	40.1	28.8	8.1	185.2	15.5	12.5	29.5	25.9	20.4	19.7	15.8	31.6	21.1	32.4	22.5	32.2	22.8	73.0	40.3	17.3	56.9	29.5	17.7	13.9	21.9	12.8	21.3	42.4	43.4	37.0	18.2	21.2	19.6	21.8	16.5	42.5	6.5	20.1	2.8	18.3	13.0	7.3	8.8	24.9	20.4	11.3	11.4	4.2	27.2	13.7	22.4	12.4	19.8	19.7	19.2	20.3	19.7	18.7	22.3	19.4	19.1	19.6	21.2	20.9	13.5	12.8	6.9	7.8	20.5	9.6	20.6	15.3	14.2	48.6	19.3	16.1	22.2	27.1	12.2	31.3	52.1	31.7	8.0	17.6	23.5	21.0	186.6	7.8	10.2	13.3	9.0	28.0	15.4	19.1	29.8	16.7	23.0	10.5	5.1	16.4	15.0	14.0	21.7	48.8	16.6	15.0	28.5	15.0	9.6	415.4	28.9	10.5	7.2	10.3	22.7	30.9	14.4	8.5	14.1	19.1	13.3	25.2	14.8	20.6	26.1	21.6	7.3	61.4	13.1	17.5	16.3	133.0	35.7	28.9	13.4	44.5	10.9	18.5	17.9	20.0
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762996-31764851	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.3"	"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.4;U-2 OS: 1.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071699			Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Cell Junctions"	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	2.7	1.1	0.4	0.0	0.4	0.2	2.5	0.5	0.9	2.4	0.4	3.7	0.0	2.5	0.1	2.5	3.9	0.0	1.2	0.4	0.3	7.4	3.1	2.0	0.6	0.4	0.5	3.8	2.1	0.0	6.1	0.1	0.4	6.0	0.2	1.2	2.3	0.1	1.0	28.3	3.9	0.1	0.4	4.8	2.6	3.6	0.4	0.2	2.2	0.0	0.1	2.5	2.2	0.4	0.4	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.7	0.4	0.2	0.2	0.2	0.5	0.0	0.1	0.7	1.4	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.7	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.9	0.4	0.3	0.4	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63970029-64019779	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 120.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		920000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	10.8	9.5	2.6	15.8	3.2	30.3	9.5	3.4	3.6	9.3	3.5	8.6	6.3	4.7	1.5	30.1	4.4	18.1	5.7	2.8	3.9	9.0	37.8	12.1	13.4	5.2	4.0	4.2	7.1	2.7	3.7	7.2	4.8	4.6	9.7	2.3	10.8	3.3	3.0	58.8	8.8	7.3	4.3	7.8	7.1	2.7	4.6	6.5	5.3	2.3	18.3	23.7	17.1	4.5	24.2	4.8	4.0	28.8	13.9	19.7	2.0	75.6	72.9	46.8	46.4	1.0	10.8	0.4	27.2	45.6	23.3	38.3	0.8	48.2	66.3	33.4	0.9	0.0	8.7	2.5	32.1	120.0	10.0	19.1	41.3	63.6	20.9	30.3	51.4	5.1	0.7	13.4	32.9	2.1	2.1	13.5	1.7	3.8	23.6	1.7	10.5	2.1	21.4	27.1	2.3	2.4	15.0	2.3	28.8	3.3	0.8	45.4	79.2	71.0	15.4	8.8	31.1	5.9	1.0	0.1	72.5	69.2	63.0	2.7	44.2	2.0	7.6	34.2	6.8	7.1	6.3	4.7	53.8	9.9	3.3	5.2	12.4	4.6	18.1	28.8	8.9	11.2	2.6	3.2	3.4	3.6	2.8	3.9	5.2	4.0	4.8	4.3	4.6	4.5	6.0	3.2	8.3	0.3	9.1	41.0	25.9	38.9	5.7	0.4	5.5	3.8	1.2	8.6	25.5	0.0	0.0	4.9	13.4	12.3	0.0	30.0	1.3	7.6	3.3	8.7	1.8	3.0	1.8	19.2	5.6	8.6	8.2	16.3	4.5	0.9	7.5	9.6	15.3	0.0	1.3	3.5	12.2	24.8	35.1	1.1	0.9	35.9	16.0	1.0	29.0	1.6	5.2	1.5	2.9	42.2	10.7	0.0	3.5	13.0	8.5	2.9	12.9	0.3	0.0	12.3	9.8	1.7	2.3	18.2	48.4	31.3	8.2	1.4	5.0	33.3
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390440-6394998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 131.3;Late spermatids: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 139.1;fHDF/TERT166: 144.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	21.8	36.5	38.8	13.9	44.7	7.3	20.1	45.1	43.0	21.2	33.9	25.3	16.8	20.9	14.4	20.6	14.6	21.5	55.8	39.1	43.0	73.7	95.3	31.3	14.6	42.7	42.6	17.9	32.8	34.2	41.9	21.6	43.3	29.4	14.9	8.5	29.0	20.0	37.9	37.9	23.8	17.6	40.9	21.1	25.4	14.0	47.5	17.8	34.0	29.4	11.0	23.6	21.0	46.8	16.4	13.1	10.1	26.5	139.1	72.2	17.1	60.4	95.0	27.7	33.0	22.0	11.9	4.7	27.4	144.0	59.3	7.4	8.4	12.7	13.0	21.0	9.6	5.1	19.5	6.0	62.3	3.7	37.4	96.0	23.4	25.9	17.7	100.9	61.6	1.7	9.1	30.5	58.9	17.0	0.1	6.5	3.9	23.2	22.3	1.2	5.5	7.0	23.9	6.2	17.0	9.7	27.6	19.5	38.5	12.9	7.3	7.0	53.9	103.0	10.9	59.1	15.4	37.6	44.0	3.5	93.7	10.8	47.1	1.9	2.5	3.4	6.4	2.1	5.0	1.5	5.5	5.0	1.3	3.1	10.0	10.1	2.5	6.6	0.6	1.7	4.7	3.2	38.8	44.7	45.1	43.0	39.1	43.0	42.7	42.6	43.3	40.9	47.5	46.8	14.1	25.6	14.4	10.7	12.2	7.9	22.8	15.3	6.8	12.6	13.7	9.0	37.7	24.3	12.8	25.8	25.0	38.8	11.5	131.3	11.7	53.4	50.0	6.2	13.0	18.6	23.8	9.9	5.8	38.2	14.4	31.4	15.8	21.0	10.8	9.4	26.7	88.5	34.1	20.2	5.5	20.3	24.4	15.5	6.2	200.7	11.5	15.8	55.2	4.7	7.8	16.4	36.0	6.6	15.5	24.7	83.1	13.5	23.1	26.0	51.7	75.1	2.4	5.2	0.0	8.9	17.1	1.4	3.1	7.5	8.0	34.3	23.3	10.2	18.0	15.4
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008972-13169103	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.4;Early spermatids: 27.9;Glandular and luminal cells: 47.4;Microglial cells: 35.6;Syncytiotrophoblasts: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.3;RPTEC TERT1: 43.7;U-2197: 30.4;U-87 MG: 57.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	4.6	4.3	1.4	1.4	1.4	0.6	8.3	1.2	1.3	7.4	8.5	6.1	15.7	4.7	16.8	5.9	6.7	10.9	6.4	1.5	2.7	18.2	20.0	7.8	1.3	2.4	2.1	7.1	5.6	11.0	2.7	20.9	2.4	5.9	7.4	2.8	6.7	3.6	0.4	25.6	16.2	3.9	1.8	2.9	4.5	6.4	3.8	5.0	24.4	2.0	1.7	5.7	5.1	2.5	1.5	2.4	1.8	0.0	14.1	20.2	11.4	0.0	3.2	2.1	8.2	18.6	9.3	0.0	1.2	0.6	18.2	25.0	0.0	7.0	3.0	0.0	0.1	0.0	5.6	26.4	1.3	0.0	0.2	11.5	21.4	8.4	2.8	7.7	1.4	4.4	0.0	33.3	23.7	0.5	0.1	0.0	0.1	2.2	2.9	2.3	4.2	15.1	43.7	18.2	0.0	0.3	0.2	2.3	0.1	3.1	18.6	0.5	3.3	9.2	3.1	30.4	2.2	0.2	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.4	1.4	1.2	1.3	1.5	2.7	2.4	2.1	2.4	1.8	3.8	2.5	3.6	6.4	22.3	5.2	0.1	2.4	5.3	2.3	4.6	0.1	5.4	5.0	17.9	4.3	4.9	9.2	0.0	28.4	1.0	3.4	7.9	3.0	27.9	18.7	5.2	4.6	0.0	2.1	0.5	4.4	13.0	5.4	4.6	47.4	1.3	5.6	1.8	20.7	2.8	0.0	0.9	5.7	6.1	2.6	0.4	11.6	3.7	2.4	0.0	35.6	0.0	12.3	3.1	0.0	0.1	3.2	6.7	2.6	0.1	2.3	10.9	18.6	3.5	0.4	0.0	6.1	0.8	1.2	0.1	4.9	2.3	46.1	1.2	2.9	7.3	2.6
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 713.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 30.8;head and neck cancer: 78.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171, HPA070372"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		530000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	25.7	1.3	0.6	0.9	0.8	0.7	2.2	3.7	2.0	78.7	0.8	1.4	0.8	1.0	1.6	713.5	4.4	0.6	5.1	0.5	0.6	2.5	1.7	5.3	1.5	1.5	0.9	3.0	3.2	0.2	3.3	1.2	1.4	4.1	0.9	1.7	89.7	4.4	1.1	73.2	1.9	0.5	0.4	2.6	1.8	2.9	0.9	1.3	2.7	0.3	40.4	1.3	144.2	0.9	1.1	2.0	1.1	1.0	0.0	0.8	17.5	0.4	0.2	1.0	1.6	1.2	1.7	1.0	2.3	1.3	0.3	24.2	2.8	2.0	0.6	2.0	3.3	1.4	16.2	5.7	0.8	0.9	1.5	1.5	9.3	0.5	2.0	0.5	0.7	3.4	1.0	1.0	0.7	17.5	0.7	1.9	0.3	1.1	2.2	1.1	0.1	1.1	0.6	2.1	1.2	1.6	0.2	21.7	0.1	1.4	1.5	1.1	0.8	1.1	4.8	2.0	0.9	1.5	1.8	0.3	0.4	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.7	2.0	0.5	0.6	1.5	0.9	1.4	0.4	0.9	0.9	0.2	12.8	1.1	2.0	0.0	0.3	4.6	63.6	4.0	0.9	1.1	0.8	0.8	5.7	18.8	0.0	0.0	1.4	0.3	0.2	29.4	2.0	0.1	0.3	0.2	0.2	0.0	0.0	1.5	0.9	0.8	3.9	0.0	0.6	4.5	0.7	0.0	0.2	0.4	0.0	1.7	0.1	6.1	0.6	0.3	0.0	0.6	0.4	0.0	1.0	0.4	0.2	0.0	1.0	1.0	2.6	0.0	0.4	0.1	7.4	0.1	0.2	2.1	0.6	0.0	0.1	1.0	0.0	0.6	34.7	1.8	1.2	0.6	1.2	0.3	6.2
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
TIGD5	FLJ14926	ENSG00000179886	"Tigger transposable element derived 5"	Q53EQ6	8	143597831-143603224	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9;Theca cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.90e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.16e-1)"	"prognostic favorable (9.16e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.04e-1)"	2.1	2.9	1.8	0.2	1.6	0.1	2.1	4.0	2.0	3.0	0.5	3.1	0.4	3.2	0.1	3.5	3.0	0.2	3.6	1.5	1.6	3.0	2.3	1.7	0.3	2.1	2.0	4.0	5.9	0.7	3.8	0.1	1.7	3.0	0.1	0.1	2.7	0.3	4.4	3.7	2.7	0.1	1.5	3.6	3.0	1.5	1.7	0.2	3.0	0.4	0.2	3.2	2.5	2.0	0.9	1.5	0.4	1.2	0.6	0.6	0.6	0.5	0.4	0.5	0.4	0.5	0.6	1.7	2.7	0.4	0.5	1.2	0.4	0.4	0.0	5.9	1.8	1.0	1.7	0.2	1.1	0.4	1.4	0.6	1.1	0.3	0.5	0.7	0.4	0.4	1.2	0.2	0.2	1.6	2.9	1.7	0.6	1.0	2.9	1.1	0.3	0.8	0.5	0.6	1.4	1.8	1.1	0.9	1.2	0.1	2.6	1.2	0.7	1.0	0.8	1.0	3.5	0.9	0.4	0.2	0.6	0.7	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	1.6	4.0	2.0	1.5	1.6	2.1	2.0	1.7	1.5	1.7	2.0	5.0	3.2	1.3	0.7	3.8	1.7	5.4	0.9	1.2	16.0	6.3	4.6	5.9	4.3	1.3	5.5	20.9	1.4	4.9	5.1	0.0	2.3	1.0	4.0	8.1	4.4	0.0	4.0	0.8	1.8	1.3	4.2	2.0	5.5	1.3	15.4	4.6	2.6	3.4	16.8	1.1	3.6	0.0	3.2	0.8	0.7	7.8	3.0	0.0	1.0	3.2	10.0	6.2	0.5	0.4	3.6	1.7	4.5	1.0	4.9	3.3	2.2	1.1	15.1	0.0	10.6	4.2	0.8	1.2	2.4	1.0	1.8	3.5	29.3	5.1	3.8
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 86.9;smooth muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	9.4	3.8	9.2	7.1	8.3	0.8	5.7	3.5	8.2	13.7	4.3	8.6	1.6	86.9	6.0	20.4	45.6	6.2	6.3	15.3	6.6	2.7	2.4	15.5	3.9	5.5	8.5	15.9	2.4	0.8	3.0	2.0	4.8	6.8	8.6	0.3	3.9	5.4	4.7	23.1	7.9	84.8	4.3	19.9	5.8	4.4	6.6	0.9	5.4	3.5	3.2	18.6	15.1	5.6	0.1	0.4	0.1	0.2	35.0	87.8	0.4	0.3	0.1	1.0	1.6	0.1	1.0	0.1	1.5	5.0	11.2	0.1	1.2	0.8	0.4	0.1	0.7	0.0	2.4	5.9	9.1	0.3	1.9	32.5	7.1	6.7	26.8	5.8	78.7	0.1	0.1	0.1	74.5	0.9	0.0	0.6	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.1	0.1	0.9	0.5	0.6	105.5	8.0	0.5	26.5	2.3	0.4	0.0	0.1	16.7	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.3	0.2	0.2	0.0	0.0	9.2	8.3	3.5	8.2	15.3	6.6	5.5	8.5	4.8	4.3	6.6	5.6	1.2	0.0	0.5	4.6	0.0	3.3	1.1	0.4	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	2.3	1.7	3.9	10.3	0.0	4.5	0.4	0.0	5.8	0.0	0.1	0.0	7.1	1.8	0.3	2.9	0.0	14.4	3.3	2.0	2.9	10.8	0.7	9.0	3.5	1.8	1.0	0.6	0.1	0.0	1.0	2.6	0.1	1.5	5.3	0.1	0.4	0.0	0.1	1.3	0.2	6.6	1.6	9.3	23.7	0.8	0.3	8.4	0.0	0.1	0.1	1.5	0.5
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347992	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 213.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	34.7	47.8	20.8	17.0	19.4	60.8	32.1	19.9	25.8	43.6	23.6	22.7	29.1	26.6	12.7	76.5	26.8	24.9	43.2	19.8	26.6	32.7	49.0	37.1	15.3	30.2	24.5	21.5	20.2	48.5	37.4	27.7	32.9	23.2	9.8	5.9	60.6	11.7	213.8	74.9	28.4	10.8	19.6	23.9	20.8	25.9	24.8	13.1	26.5	68.6	12.7	19.5	45.0	22.1	15.8	15.3	8.8	14.3	58.3	34.9	42.3	15.5	43.8	28.4	31.1	21.5	14.3	6.2	28.0	45.4	18.3	7.3	8.6	15.6	9.9	18.7	21.3	5.3	17.1	43.8	58.6	10.8	23.6	49.8	19.2	39.6	13.3	18.5	19.8	11.6	10.3	15.3	14.1	13.8	8.2	27.5	7.0	18.9	8.6	14.9	12.3	13.2	10.9	11.3	14.9	12.1	34.1	34.8	34.5	7.3	18.0	16.7	22.0	34.0	29.4	27.3	7.7	18.0	12.4	16.7	45.7	10.5	11.4	18.6	100.9	44.5	19.3	60.7	15.6	13.6	29.5	18.4	48.0	11.0	22.6	15.7	129.1	15.1	66.2	25.9	48.2	63.3	20.8	19.4	19.9	25.8	19.8	26.6	30.2	24.5	32.9	19.6	24.8	22.1	10.1	22.4	36.9	8.8	12.7	12.7	10.3	29.5	7.4	11.1	19.1	11.0	23.2	15.7	33.0	12.9	12.5	64.6	13.8	41.6	27.4	40.9	29.9	32.0	17.8	14.2	16.2	9.7	9.3	38.9	57.1	22.6	15.3	48.0	22.8	10.4	16.1	34.0	60.8	11.8	15.2	18.1	50.8	33.5	35.2	21.4	11.5	45.2	19.6	7.5	34.0	19.5	9.2	6.6	13.2	34.2	21.5	12.8	5.7	11.9	55.3	34.9	24.2	8.2	6.6	16.6	15.4	23.5	5.6	17.3	21.9	170.2	18.2	13.4	15.2	10.7
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583589	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;ovary: 49.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		17000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	21.5	3.5	18.2	1.4	30.3	0.8	5.2	17.7	27.1	2.1	0.0	2.3	1.6	4.6	3.5	13.1	11.5	2.5	2.2	27.7	10.7	11.3	0.8	3.3	1.3	20.9	22.6	49.7	9.8	0.9	0.9	5.7	18.6	2.6	0.9	2.6	1.9	6.1	0.9	13.8	2.4	4.4	14.4	5.5	3.2	18.8	15.7	0.4	1.1	1.8	3.7	2.1	4.1	32.0	10.3	6.7	20.7	22.7	18.9	12.8	69.2	14.6	9.3	14.2	13.1	37.7	3.4	0.4	18.3	11.9	19.9	23.7	23.3	3.6	6.5	5.8	15.5	3.2	20.2	18.1	13.3	5.2	0.4	4.1	7.3	10.9	3.6	5.8	10.6	9.8	19.1	4.3	7.9	9.8	2.4	1.0	47.7	16.0	6.7	31.9	18.6	3.8	1.2	19.7	24.6	7.0	13.7	21.6	16.3	29.8	17.8	6.0	8.4	28.0	12.2	21.0	22.5	1.7	3.5	3.1	17.2	33.8	17.2	1.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.5	0.3	0.1	0.3	0.1	0.1	18.2	30.3	17.7	27.1	27.7	10.7	20.9	22.6	18.6	14.4	15.7	32.0	3.4	3.2	1.1	17.6	0.9	6.8	8.5	0.4	0.6	2.7	2.2	2.2	2.9	2.8	0.7	3.7	6.2	2.9	1.1	1.3	0.0	3.9	3.6	1.1	13.0	5.4	1.8	0.0	42.4	3.6	10.2	10.5	8.6	1.9	0.0	7.6	9.7	0.4	1.2	0.0	4.6	0.9	0.0	1.9	1.3	5.1	44.4	0.9	8.8	1.0	0.1	8.3	1.0	29.1	46.8	4.6	0.1	47.0	0.3	6.4	1.2	1.2	0.5	4.0	0.0	3.9	4.3	4.0	6.5	4.2	10.9	18.9	0.7	5.8	2.3	5.7
VPS51	"ANG2, ANG3, C11orf2, C11orf3, FFR"	ENSG00000149823	"VPS51 subunit of GARP complex"	Q9UID3	11	65089324-65111862	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039650, HPA061447"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"	Nucleoli	"HPA039650: AB_10673147, HPA061447: AB_2684521"	"unprognostic (2.36e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.41e-9)"	"unprognostic (7.77e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.18e-1)"	48.5	37.8	19.0	34.9	23.1	60.9	46.6	22.0	30.7	45.6	20.4	55.4	52.9	54.4	7.3	42.5	46.1	20.3	45.3	22.5	15.5	33.7	36.2	34.2	48.6	18.5	18.6	83.8	120.3	37.4	28.6	22.2	20.2	38.1	25.1	20.3	65.5	27.7	84.2	71.2	49.7	22.7	14.3	40.9	70.3	28.4	17.2	46.7	39.7	42.9	32.5	45.2	38.1	21.5	71.8	74.5	35.7	44.4	15.5	38.5	72.1	27.5	53.2	52.6	38.8	55.2	88.7	118.0	76.1	51.4	27.3	60.0	37.9	59.3	19.2	69.6	62.1	72.5	72.6	55.1	51.3	77.1	65.0	66.8	39.9	39.0	32.1	41.6	58.4	55.0	73.6	82.9	21.7	95.1	105.8	83.0	59.8	30.7	61.5	67.5	17.5	150.7	36.2	76.2	61.5	87.8	20.7	110.9	71.8	21.0	93.7	39.1	48.1	35.2	32.0	45.4	39.7	115.7	92.2	68.9	39.9	28.0	26.3	10.6	15.0	15.4	17.9	15.8	21.2	22.4	25.2	27.1	22.1	21.2	23.3	20.7	8.0	30.6	16.0	19.1	17.7	18.3	19.0	23.1	22.0	30.7	22.5	15.5	18.5	18.6	20.2	14.3	17.2	21.5	49.8	19.2	47.7	18.9	77.3	49.1	66.3	46.0	58.6	64.7	76.5	67.8	5.8	44.3	27.8	31.3	29.2	78.4	73.7	156.5	62.6	49.2	77.5	25.6	35.0	46.5	95.8	50.5	21.8	120.5	79.4	38.8	45.9	34.4	37.5	47.3	55.3	52.5	45.5	67.3	24.1	110.0	32.6	54.0	30.6	222.4	53.4	36.1	49.8	15.9	71.3	65.9	89.6	21.6	28.0	51.2	144.4	54.5	66.4	45.1	158.7	75.9	16.1	52.5	26.3	49.3	44.4	40.3	31.4	52.3	54.8	115.3	64.0	61.5	170.5	51.0
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190196-5233840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 255.9;Spermatocytes: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	31.1	30.9	38.8	22.9	40.7	47.0	30.8	35.2	41.8	27.3	37.1	33.9	24.7	32.1	26.3	35.8	29.0	23.2	38.0	42.8	38.6	32.2	35.7	26.4	30.2	36.3	39.1	28.2	37.1	38.2	30.6	32.8	38.7	28.7	20.2	19.1	43.5	28.2	41.3	47.1	26.7	26.8	37.0	29.6	33.6	53.8	38.7	36.8	27.4	45.0	29.2	27.1	30.0	39.8	67.5	42.1	40.4	69.4	60.7	63.3	62.0	58.7	66.9	61.2	64.2	41.2	60.9	47.7	43.9	73.8	76.0	48.2	41.2	47.8	47.4	24.9	64.1	32.7	39.7	45.8	59.9	51.8	34.4	66.9	56.4	69.7	38.3	60.9	86.3	64.3	94.2	41.9	56.2	69.9	39.6	90.0	84.3	35.9	61.1	64.3	57.7	79.5	40.4	32.3	50.3	75.4	43.0	72.8	52.4	67.3	44.8	97.2	69.2	38.9	80.9	65.6	44.4	75.0	75.2	54.7	63.4	59.3	58.8	0.4	4.7	13.6	4.4	6.0	2.8	5.7	5.8	8.0	4.2	6.2	7.5	4.7	9.1	2.6	4.2	6.4	9.0	2.2	38.8	40.7	35.2	41.8	42.8	38.6	36.3	39.1	38.7	37.0	38.7	39.8	40.2	38.5	31.5	16.3	51.6	54.9	39.5	13.9	39.3	71.5	49.4	50.5	37.0	42.9	17.6	18.4	62.6	89.4	62.7	42.6	72.4	43.0	195.8	50.0	38.1	37.9	39.5	125.0	19.7	41.8	96.6	43.1	34.7	48.0	31.1	54.8	54.7	60.4	69.1	47.1	19.6	42.6	18.3	61.4	44.8	255.9	42.6	55.9	44.4	20.6	64.5	89.5	44.3	13.6	23.5	55.6	37.0	56.1	67.7	97.7	48.7	80.6	26.4	52.8	52.6	39.7	39.4	233.0	117.3	49.8	71.0	150.8	46.8	44.1	43.0	69.8
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.2;Proximal enterocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	24.9	35.3	12.9	18.1	15.8	30.0	27.9	15.8	12.9	25.3	11.7	55.4	61.9	16.1	6.4	95.4	17.9	11.0	25.2	11.2	13.6	19.7	48.4	25.0	16.2	18.3	17.5	12.7	29.9	15.6	20.0	9.0	17.3	30.5	18.6	6.5	40.2	12.8	40.6	111.9	71.2	9.9	15.8	31.6	37.7	6.1	17.7	9.0	25.5	17.6	15.2	20.4	44.4	17.9	16.5	29.0	2.5	8.8	12.7	7.2	34.7	11.1	13.1	11.4	13.2	19.5	23.4	7.2	19.5	12.6	9.1	24.5	8.1	15.7	2.4	39.4	9.1	12.0	51.4	13.1	18.6	9.2	31.7	9.4	54.8	15.6	19.3	15.3	9.1	1.1	17.3	32.2	6.7	31.2	0.2	20.7	8.7	26.4	23.8	6.8	1.9	45.6	17.2	16.9	16.1	16.5	21.4	56.5	8.9	10.6	35.2	30.7	7.7	7.4	12.9	14.8	9.5	38.1	25.1	7.6	17.3	30.3	8.6	0.4	1.5	1.3	0.6	1.4	0.2	0.6	0.7	0.3	0.9	0.7	0.6	0.2	2.3	0.7	1.2	0.0	1.0	2.5	12.9	15.8	15.8	12.9	11.2	13.6	18.3	17.5	17.3	15.8	17.7	17.9	6.5	9.6	0.0	11.1	8.5	35.2	9.3	8.8	29.6	13.6	35.2	15.6	2.6	18.6	7.1	5.5	2.1	11.9	6.9	135.2	11.7	13.3	4.3	15.4	6.7	5.6	6.7	6.1	1.0	15.1	14.6	4.9	27.5	21.3	5.7	2.8	6.1	29.9	14.8	16.8	1.1	32.7	14.2	28.7	40.3	8.3	9.0	20.7	16.0	4.7	25.8	5.4	11.3	0.0	8.6	16.8	57.7	7.2	6.8	24.9	158.5	10.0	4.2	10.3	0.0	3.2	5.7	0.5	1.2	51.7	53.6	27.5	11.3	4.4	38.5	24.4